These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12020489)

  • 21. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.
    Hamilton MA; Stevenson LW; Child JS; Moriguchi JD; Woo M
    Am J Cardiol; 1990 May; 65(18):1209-12. PubMed ID: 2186605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
    Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
    Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.
    Murdoch DR; McDonagh TA; Byrne J; Blue L; Farmer R; Morton JJ; Dargie HJ
    Am Heart J; 1999 Dec; 138(6 Pt 1):1126-32. PubMed ID: 10577444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.
    Abraham WT; Lowes BD; Ferguson DA; Odom J; Kim JK; Robertson AD; Bristow MR; Schrier RW
    J Card Fail; 1998 Mar; 4(1):37-44. PubMed ID: 9573502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.
    Remme WJ; van der Ent M; Bartels GL; van Schelven D; van Hoogenhuyze DC; Krauss XH; Kruijssen HA; Storm CJ
    Cardiovasc Drugs Ther; 1996 May; 10(2):137-44. PubMed ID: 8842505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
    Amin DK; Shah PK; Hulse S; Shellock F
    Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
    Cusick DA; Pfeifer PB; Quigg RJ
    Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
    Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
    JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan.
    Moe GW; Rouleau JL; Charbonneau L; Proulx G; Arnold JM; Hall C; de Champlain J; Barr A; Sirois P; Packer M
    Am Heart J; 2000 Apr; 139(4):587-95. PubMed ID: 10740139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and medium term results of tailored therapy for heart failure.
    Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada.
    Parker AB; Azevedo ER; Baird MG; Smith SJ; Arnold JM; Humen DP; Moe GW; Parker JO; Butt RW; Parker JD
    Am Heart J; 1999 Nov; 138(5 Pt 1):843-8. PubMed ID: 10539814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
    Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H
    Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.
    Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O
    Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
    Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G
    J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.